Expert Opinion on Pharmacotherapy, Volume 16, Issue 11 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 16, Issue 11 (2015)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Volume 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Use of nitrates in ischemic heart disease
Cocco Giuseppe (Professor) MD FESC, Jerie Paul MD & Iselin Hans-Ulrich (President) (Formerly Head of the Medical Department of the Gesundheitszentrum Fricktal (Rheinfelden Hospital)) MD
Pages: 1567-1572
Published online: 01 Jun 2015
AbstractforUse of nitrates in ischemic heart disease | Full Text | References | PDF (260.4 KB)
  • 9603 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
Marco Proietti & Gregory YH Lip
Pages: 1573-1576
Published online: 16 Jun 2015
AbstractforAntidotes to non-vitamin K oral anticoagulants: necessary or not? | Full Text | References | PDF (148.3 KB)
  • 2879 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Safety and efficacy of canagliflozin in Japanese patients with type 2 diabetes mellitus: post hoc subgroup analyses according to body mass index in a 52-week open-label study
Nobuya Inagaki, Maki Goda, Shoko Yokota, Nobuko Maruyama & Hiroaki Iijima
Pages: 1577-1591
Published online: 24 Jun 2015
AbstractforSafety and efficacy of canagliflozin in Japanese patients with type 2 diabetes mellitus: post hoc subgroup analyses according to body mass index in a 52-week open-label study | Full Text | References | PDF (490.2 KB) | Supplemental
  • 766 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain
Warren Wen PhD, Steve Sitar MD, Shau Yu Lynch PhD, Ellie He PhD & Steven R Ripa MD
Pages: 1593-1606
Published online: 26 Jun 2015
AbstractforA multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain | Full Text | References | PDF (678.9 KB)
  • 2810 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Article
Meta-analysis of the efficacy of the fentanyl iontophoretic transdermal system versus intravenous patient-controlled analgesia in postoperative pain management
Raymond S Sinatra, Eugene R Viscusi, Li Ding, Hassan Danesi, James B Jones & Stefan Grond
Pages: 1607-1613
Published online: 08 Jun 2015
AbstractforMeta-analysis of the efficacy of the fentanyl iontophoretic transdermal system versus intravenous patient-controlled analgesia in postoperative pain management | Full Text | References | PDF (493.1 KB)
  • 1550 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Review

The optimal combination therapy for the treatment of early rheumatoid arthritis
Diederik De Cock Msc, Kristien Van der Elst Msc RN, Sabrina Meyfroidt Msc, Patrick Verschueren PhD MD & René Westhovens PhD MD
Pages: 1615-1625
Published online: 10 Jun 2015
AbstractforThe optimal combination therapy for the treatment of early rheumatoid arthritis | Full Text | References | PDF (490.1 KB)
  • 659 Views
  • 13 CrossRef citations
  • 0Altmetric
Advances in pharmacotherapy to treat kidney transplant rejection
Jamal Bamoulid, Oliver Staeck, Fabian Halleck, Michael Dürr, Alexander Paliege, Nils Lachmann, Susanne Brakemeier, Lutz Liefeldt & Klemens Budde
Pages: 1627-1648
Published online: 09 Jul 2015
AbstractforAdvances in pharmacotherapy to treat kidney transplant rejection | Full Text | References | PDF (491.6 KB)
  • 706 Views
  • 9 CrossRef citations
  • 0Altmetric
Advancements in the treatment of agitation in Alzheimer’s disease
Inga M Antonsdottir BS, Jessica Smith BS, Melanie Keltz BA & Anton P Porsteinsson MD
Pages: 1649-1656
Published online: 09 Jul 2015
AbstractforAdvancements in the treatment of agitation in Alzheimer’s disease | Full Text | References | PDF (195.9 KB)
  • 1750 Views
  • 26 CrossRef citations
  • 0Altmetric
Pharmacotherapy options for labor induction
Deborah A Wing & Lili Sheibani
Pages: 1657-1668
Published online: 06 Jul 2015
AbstractforPharmacotherapy options for labor induction | Full Text | References | PDF (237.7 KB)
  • 688 Views
  • 17 CrossRef citations
  • 0Altmetric
Pharmacological treatment for generalized anxiety disorder in adults: an update
Jennifer A Reinhold (Associate Professor of Clinical Pharmacy) BA PharmD BCPS BCPP & Karl Rickels (Stuart and Emily Mudd Professor of Human Behavior and Psychiatry) MD
Pages: 1669-1681
Published online: 09 Jul 2015
AbstractforPharmacological treatment for generalized anxiety disorder in adults: an update | Full Text | References | PDF (301.4 KB)
  • 2798 Views
  • 51 CrossRef citations
  • 0Altmetric
Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis – still of value for our patients?
Vladimir Tesar MD PhD & Zdenka Hruskova
Pages: 1683-1702
Published online: 06 Jul 2015
AbstractforConventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis – still of value for our patients? | Full Text | References | PDF (356.9 KB)
  • 401 Views
  • 3 CrossRef citations
  • 0Altmetric
Advances in pharmacotherapy for secondary hyperparathyroidism
Mariano Rodríguez MD PhD & María E Rodríguez-Ortiz PhD
Pages: 1703-1716
Published online: 09 Jul 2015
AbstractforAdvances in pharmacotherapy for secondary hyperparathyroidism | Full Text | References | PDF (554.4 KB)
  • 437 Views
  • 8 CrossRef citations
  • 0Altmetric

Drug Evaluation

Odanacatib for the treatment of osteoporosis
Miranda K Boggild MD, Olga Gajic-Veljanoski MD MSc PhD, Heather McDonald-Blumer MD MSc, Rowena Ridout MD, Lianne Tile MD MEd, Robert Josse MD & Angela M Cheung MD PhD
Pages: 1717-1726
Published online: 06 Jul 2015
AbstractforOdanacatib for the treatment of osteoporosis | Full Text | References | PDF (447.6 KB)
  • 543 Views
  • 11 CrossRef citations
  • 0Altmetric
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia
Zubaid Rafique (Assistant Professor) MD FACEP, William Frank Peacock (Professor) MD FACEP, Frank LoVecchio (Co-Medical Director, Professor) DO MPH FACEP & Phillip D Levy (Associate Professor, Associate Chair for Research) MD MPH FACEP
Pages: 1727-1734
Published online: 09 Jul 2015
AbstractforSodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia | Full Text | References | PDF (410.7 KB)
  • 1123 Views
  • 12 CrossRef citations
  • 0Altmetric

Further Readings

Related articles
Pages: 1-2
Published online: 09 Jul 2015
CitationforRelated articles | Full Text | PDF (93.4 KB)
  • 45 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen et al.
Review Article | Published online: 28 May 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña et al.
Review Article | Published online: 28 May 2024
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 27 May 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 27 May 2024
View all latest articles